Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-22T06:46:35.525Z Has data issue: false hasContentIssue false
  • English
  • Français

Hand Hygiene, and Not Ertapenem Use, Contributed to Reduction of Carbapenem-Resistant Pseudomonas aeruginosa Rates

Published online by Cambridge University Press:  02 January 2015

Rodrigo Pires dos Santos ,
Thalita Jacoby ,
Denise Pires Machado ,
Thiago Lisboa ,
Sandra Ludwig Gastal ,
Fabiano Márcio Nagel ,
Nádia Mora Kuplich ,
Loriane Konkewicz ,
Carem Gorniak Lovatto  and
Márcia Rosane Pires
...Show all authors
Rodrigo Pires dos Santos*
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil Infectious Disease Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Thalita Jacoby
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Denise Pires Machado
Affiliation:
Microbiology Unit, Service of Clinical Pathology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Thiago Lisboa
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Sandra Ludwig Gastal
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Fabiano Márcio Nagel
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Nádia Mora Kuplich
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Loriane Konkewicz
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Carem Gorniak Lovatto
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Márcia Rosane Pires
Affiliation:
Hospital Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Luciano Zubaran Goldani
Affiliation:
Infectious Disease Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
*
Rua Ramiro Barcelos 2350, CEP: 90035-903, Porto Alegre, RS, Brazil ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To evaluate the impact of ertapenem use in Pseudomonas aeruginosa carbapenem resistance, taking into account the volume of antimicrobial consumption, the consumption by the entire hospital of alcohol-based antiseptic hand rub, and the density rate of invasive practices.

Design.

Before-and-after trial.

Setting.

A tertiary care university hospital in southern Brazil.

Methods.

Ertapenem was first added to the hospital formulary in June 2006, and it was excluded in February 2009. We evaluated Pseudomonas aeruginosa resistance rates through 3 study periods: period 1, before ertapenem use (17 months); period 2, during ertapenem use (33 months); and period 3, after exclusion of ertapenem (15 months).

Results.

After introduction of ertapenem, there was a significant decrease in median consumption of imipenem or meropenem, from 2.6 to 2.2 defined daily doses (DDDs) per 100 patient-days (level change from 0.04 to -1.08; P < .01), and an increase in the use of these medications after ertapenem exclusion, from 2.2 to 3.3 DDDs per 100 patient-days (level change from -0.14 to 0.91; P < .01), by segmented regression analysis. There was no difference in the incidence density of carbapenem-resistant P. aeruginosa infection related to ertapenem use throughout the study periods. However, by multiple regression analysis, the reduction in the rate of carbapenem-resistant P. aeruginosa infection correlated significantly with the increase in the volume of alcohol used as hand sanitizer, which was from 660.7 mL per 100 patient-days in period 1 to 2,955.1 mL per 100 patient-days in period 3 (P = .04). Ertapenem use did not impact the rate of carbapenem-resistant P. aeruginosa infection.

Conclusions.

Use of alcohol-based hand gel, rather than ertapenem, was associated with a reduction in the rates of carbapenem-resistant P. aeruginosa infection. Measures to reduce resistance must include factors other than just antimicrobial stewardship programs alone.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 6 , June 2011 , pp. 584 - 590
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kollef, MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis 2008;47(suppl 1):S3–S13.CrossRefGoogle ScholarPubMed
2.Dellit, TH, Owens, RC, McGowan, JE Jr, et al.Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar
3.Livermore, DM, Mushtaq, S, Warner, M. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other car-bapenems. J Antimicrob Chemother 2005;55:306–311.Google Scholar
4.Goff, DA, Mangino, JE. Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem. J Infect 2008;57:123–127.CrossRefGoogle ScholarPubMed
5.Lima, ALL, Olivera, PR, Paula, AP, Dal-Paz, K, Rossi, F, Zumiotti, AV. The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study. Infect Control Hosp Epidemiol 2009;30:487–490.Google Scholar
6.Goldstein, EJ, Citron, DM, Peraino, V, Elgourt, T, Meibohm, AR, Lu, S. Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53:5122–5126.Google Scholar
7.Eagye, KJ, Nicolau, DP. Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals. Infect Control Hosp Epidemiol 2010;31:485–490.CrossRefGoogle ScholarPubMed
8.Pagani, L. Antimicrobial stewardship: there's no such thing as too much. Am J Respir Crit Care Med 2010;181:94.Google Scholar
9.Natsch, S, Hekster, YA, de Jong, R, Heerdink, ER, Herings, RM, van der Meer, JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998;17:20–24.Google Scholar
10.Edwards, JR, Peterson, KD, Andrus, ML, et al.National Healthcare Safety Network (NHSN) report, data summary for 2006. Am J Infect Control 2007;35:290–301.CrossRefGoogle ScholarPubMed
11.Hindier, JF, Stelling, J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007;44:867–873.Google Scholar
12.Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobi-cally. Approved standard M7-A7. 7th ed. Wayne, PA: CLSI; 2006.Google Scholar
13.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L. Healthcare infection control management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(suppl 2):S165–S193.CrossRefGoogle ScholarPubMed
14.Shardell, M, Harris, AD, El-Kamary, SS, Furuno, JP, Miller, RR, Perencevich, EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007;45:901–907.Google Scholar
15.Wagner, AK, Soumerai, SB, Zhang, F, Ross-Degnan, D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299–309.Google Scholar
16.Zhang, F, Wagner, AK, Soumerai, SB, Ross-Degnan, D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol 2009;62:143–148.Google Scholar
17.Falagas, ME, Kopterides, P. Risk factors for the isolation of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 2006;64:7–15.Google Scholar
18.Tacconelli, E, De Angelis, G, Cataldo, MA, et al.Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother 2009;53:4264–4269.Google Scholar
19.Lodise, TP, Miller, CD, Graves, J, et al.Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob Agents Chemother 2007;51:417–422.Google Scholar
20.Lautenbach, E, Weiner, MG, Nachamkin, I, Bilker, WB, Sheridan, A, Fishman, NO. Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol 2006;27:893–900.Google Scholar
21.Fortaleza, CM, Freire, MP, Filho, DC, de Carvalho Ramos, M. Risk factors for recovery of imipenem- or ceftazidime-resistant Pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil. Infect Control Hosp Epidemiol 2006;27:901–906.CrossRefGoogle ScholarPubMed
22.Lodise, TP Jr, Miller, C, Patel, N, Graves, J, McNutt, LA. Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates. Infect Control Hosp Epidemiol 2007;28:959–965.Google Scholar
23.Eagye, KJ, Kuti, JL, Nicolau, DP. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 2009;30:746–752.CrossRefGoogle ScholarPubMed
24.Carling, P, Fung, T, Killion, A, Terrin, N, Barza, M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003;24:699–706.CrossRefGoogle Scholar
25.Liebowitz, LD, Blunt, MC. Modification in prescribing practices for third-generation cephalosporins and ciprofloxacin is associated with a reduction in methicillin-resistant Staphylococcus aureus bacteraemia rate. J Hosp Infect 2008;69:328–336.CrossRefGoogle ScholarPubMed
26.Pakyz, AL, Oinonen, M, Polk, RE. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53:1983–1986.Google Scholar
27.Fukushima, Y, Fukushima, F, Kamiya, K, et al.Relation between the antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008. Intern Med 2010;49:1333–1340.Google Scholar
28.Pires Dos Santos, R, Konkewicz, LR, Nagel, F, et al.The 2009 H1N1 influenza A pandemic and hand hygiene practices in a hospital in the south of Brazil. Infect Control Hosp Epidemiol 2010;31:1313–1315.CrossRefGoogle Scholar
29.Boyce, JM, Pittet, D. Healthcare Infection Control Practices Advisory Committee. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Re-comm Rep 2002;51:1–45.Google Scholar
30.Pittet, D, Hugonnet, S, Harbarth, S, et al.Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection control programme. Lancet 2000;356:1307–1312.Google Scholar
31.Apisarnthanarak, A, Pinitchai, U, Thongphubeth, K, Yuekyen, C, Warren, DK, Fraser, VJ. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008;47:760–767.Google Scholar
32.Eckmanns, T, Schwab, F, Bessert, J, et al.Hand rub consumption and hand hygiene compliance are not indicators of pathogen transmission in intensive care units. J Hosp Infect 2006;63:406–411.Google Scholar
33.Crivaro, V, Di Popolo, A, Caprio, A, et al.Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures. BMC Infect Dis 2009;9:70.CrossRefGoogle Scholar
34.Pitten, FA, Panzig, B, Schröder, G, Tietze, K, Kramer, A. Transmission of a multiresistant Pseudomonas aeruginosa strain at a German university hospital. J Hosp Infect 2001;47:125–130.Google Scholar